Advisors Asset Management Inc. Sells 16,486 Shares of GE HealthCare Technologies Inc. $GEHC

Advisors Asset Management Inc. lowered its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 17.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 78,132 shares of the company’s stock after selling 16,486 shares during the quarter. Advisors Asset Management Inc.’s holdings in GE HealthCare Technologies were worth $5,868,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in GE HealthCare Technologies by 1.4% in the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after purchasing an additional 703,903 shares during the last quarter. Dodge & Cox boosted its position in shares of GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares in the last quarter. State Street Corp boosted its position in shares of GE HealthCare Technologies by 1.9% in the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock worth $1,456,271,000 after purchasing an additional 372,755 shares in the last quarter. Geode Capital Management LLC grew its stake in GE HealthCare Technologies by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock worth $881,060,000 after buying an additional 231,302 shares during the last quarter. Finally, Norges Bank acquired a new position in GE HealthCare Technologies during the 2nd quarter valued at about $468,120,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $78.65 on Friday. The firm has a market cap of $35.84 billion, a PE ratio of 17.25, a PEG ratio of 1.75 and a beta of 1.08. The firm has a fifty day moving average of $82.54 and a 200 day moving average of $77.60. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.GE HealthCare Technologies’s revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be issued a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.07%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on GEHC shares. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their price target for the stock from $73.00 to $77.00 in a report on Thursday, January 15th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 price objective on shares of GE HealthCare Technologies in a report on Friday, January 9th. Evercore increased their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Citigroup boosted their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, December 11th. Finally, Wells Fargo & Company upped their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a report on Thursday, February 5th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and a consensus price target of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.